Skip to content
Assyro AI
FDA Orange Book · active-ingredient family

Dexamethasone acetate

Dexamethasone acetate: 1 brand, 2 generics; first approved May 24, 1982; generic available.

Generic availableHas discontinued products
Generic status & protection

Generic available: 2 ANDA applications approved.

Brands (NDA)
1
Generics (ANDA)
2
Listed patents
0
Presentations
3

Brand (NDA) products

Originator applications
  • NDA 016675
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 8MG BASE/MLINJECTABLEINJECTIONDiscontinued

Generic (ANDA) products (2)

Abbreviated applications
  • DEXAMETHASONE ACETATE
    ANDA 0877111982
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 16MG BASE/MLINJECTABLEINJECTIONDiscontinued
  • DEXAMETHASONE ACETATE
    ANDA 084315
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    EQ 8MG BASE/MLINJECTABLEINJECTIONDiscontinued

Listed patents

Orange Book patent file

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Approval history

FDA approval span
First approval
44 yr 11 mo ago
Most recent approval
44 yr 11 mo ago

All 3 applications were approved in 1982.

Brand (NDA) 133%
Generic (ANDA) 267%

Dexamethasone acetate: frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.